Search research articles
Contact Us
Filters
Showing results (251-260 of 266) with videos related to
Page
of 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2012
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma
Shahab Asgharzadeh, Jill A Salo, Lingyun Ji, et al.
Genome Research
|
August 16, 2020
Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastoma
Gonzalo Lopez, Karina L Conkrite, Miriam Doepner, et al.
The Lancet. Oncology
|
July 30, 2013
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
Susan G Kreissman, Robert C Seeger, Katherine K Matthay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study
Suzanne Shusterman, Wendy B London, Stephen D Gillies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2017
Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis
Araz Marachelian, Judith G Villablanca, Cathy W Liu, et al.
Oncotarget
|
February 22, 2018
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group
Risa Niemas-Teshiba, Ryosuke Matsuno, Larry L Wang, et al.
Cancer Letters
|
December 20, 2015
MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma
Shile Zhang, Jun S Wei, Samuel Q Li, et al.
Pediatric Blood & Cancer
|
June 30, 2012
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
Rie Suganuma, Larry L Wang, Hideki Sano, et al.
Oncogene
|
January 24, 2012
Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma
E L Carpenter, E A Haglund, E M Mace, et al.
Nature Genetics
|
May 5, 2009
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Mario Capasso, Marcella Devoto, Cuiping Hou, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 266) with videos related to
Sort By:
Page
of 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2012
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma
Shahab Asgharzadeh, Jill A Salo, Lingyun Ji, et al.
Genome Research
|
August 16, 2020
Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastoma
Gonzalo Lopez, Karina L Conkrite, Miriam Doepner, et al.
The Lancet. Oncology
|
July 30, 2013
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
Susan G Kreissman, Robert C Seeger, Katherine K Matthay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study
Suzanne Shusterman, Wendy B London, Stephen D Gillies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2017
Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis
Araz Marachelian, Judith G Villablanca, Cathy W Liu, et al.
Oncotarget
|
February 22, 2018
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group
Risa Niemas-Teshiba, Ryosuke Matsuno, Larry L Wang, et al.
Cancer Letters
|
December 20, 2015
MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma
Shile Zhang, Jun S Wei, Samuel Q Li, et al.
Pediatric Blood & Cancer
|
June 30, 2012
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
Rie Suganuma, Larry L Wang, Hideki Sano, et al.
Oncogene
|
January 24, 2012
Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma
E L Carpenter, E A Haglund, E M Mace, et al.
Nature Genetics
|
May 5, 2009
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Mario Capasso, Marcella Devoto, Cuiping Hou, et al.
Page
of 27